We recently developed a general method for determining tissue sites of degradation of plasma proteins in vivo that made use of covalently attached radioactive sucrose. On degradation of the protein, the sucrose remained trapped in the cells as a cumulative marker of protein degradation. The method described here depends on the same principles, but uses an adduct of cellobiose and tyramine that is radioiodinated to high specific radioactivity and then covalently attached to protein. Use of the radioiodinated ligand increases the sensitivity of the method at least 100-fold and allows simplified tissue analysis. Proteins derivatized with the radioiodinated ligand were recognized as underivatized proteins both in vitro and in vivo. On degradation of derivatized low-density lipoprotein, the rate of leakage from cultured fibroblasts was only 5% during 24h. Similarly, on injection of labelled proteins into rats and rabbits, urinary excretion of the label was in all cases less than 10% of total labelled catabolic products recovered 24 h after injection. Examination of the tissue contents of label at two times after injection of labelled asialofetuin or apolipoprotein A1 in rats, and asialotransferrin in rabbits showed that the label did not detectably redistribute between tissues after initial uptake and catabolism; a significant leakage from liver was quantitatively accounted for by label appearing in gut contents and faeces. A simple double-label method was devised to provide a correction for intact protein in trapped plasma, the extravascular spaces, and within cells. By using this method it becomes unnecessary to fractionate tissue samples.
(Received 22 November 1982/Accepted 11 March 1983) We recently developed a general method for determining tissue sites of degradation of plasma proteins in vivo that made use of covalently attached radioactive sucrose. On degradation of the protein, the sucrose remained trapped in the cells as a cumulative marker of protein degradation. The method described here depends on the same principles, but uses an adduct of cellobiose and tyramine that is radioiodinated to high specific radioactivity and then covalently attached to protein. Use of the radioiodinated ligand increases the sensitivity of the method at least 100-fold and allows simplified tissue analysis. Proteins derivatized with the radioiodinated ligand were recognized as underivatized proteins both in vitro and in vivo. On degradation of derivatized low-density lipoprotein, the rate of leakage from cultured fibroblasts was only 5% during 24h. Similarly, on injection of labelled proteins into rats and rabbits, urinary excretion of the label was in all cases less than 10% of total labelled catabolic products recovered 24 h after injection. Examination of the tissue contents of label at two times after injection of labelled asialofetuin or apolipoprotein A1 in rats, and asialotransferrin in rabbits showed that the label did not detectably redistribute between tissues after initial uptake and catabolism; a significant leakage from liver was quantitatively accounted for by label appearing in gut contents and faeces. A simple double-label method was devised to provide a correction for intact protein in trapped plasma, the extravascular spaces, and within cells. By using this method it becomes unnecessary to fractionate tissue samples.
Until recently there was no general method available for accurately quantifying the tissue sites of degradation of plasma proteins. Proteins labelled by conventional methods, most importantly by direct radioiodination, yield radiolabelled catabolic products that rapidly escape the cells for excretion as iodide or iodotyrosine. Consequently the label residual in the cells at any time need bear no direct relationship to the ongoing rate of catabolism by those cells.
We have described a general approach to this problem (Pittman & Steinberg, 1978; Pittman et al., 1979a) . A similar approach was described by Van Zile et al. (1979) . We (Pittman et al., 1979a (Pittman et al., , 1982a . Thus the 14C accumulating within a tissue was an integrated measure of ['4C] sucrose-labelled protein that had been catabolized by that tissue. It can be shown that, in any case in which the labelled protein is introduced into the same compartment where newly synthesized tracee protein enters, the accumulation of label at very long times after injection is in proportion to the mass of protein degraded (Pittman et al., 1979b; Carew & Beltz, 1982) . Thus the label distribution is in proportion to their contributions to overall protein degradation.
However, the sucrose-labelling method is limited by the maximum specific radioactivities that can be obtained. It would be highly desirable to have available an intracellularly trapped label analogous to ['4C]sucrose but incorporating radioiodine at high specific radioactivity. This would allow more precise assay of tissues of low degradative capacity, and the ability to trace the fates of proteins that are catabolized slowly or proteins present at very low concentrations in plasma. DeJong et al. (1981, 1982) prepared and used an intracellularly trapped label that made use of a radioiodinated derivative of sucrose. However, because of a high rate of leakage of label to urine and faeces, use of the label would be restricted mainly to rapidly catabolized proteins.
In the present paper we describe the preparation and use of a radioiodinated trapped label, an adduct of tyramine and cellobiose attached to protein using cyanuric chloride, which is analogous to the sucrose label previously described. We show that proteins derivatized with this label are recognized as underivatized proteins by biological systems, and that the label indeed is adequately trapped intracellularly after uptake and catabolism of the protein. We further show than an internal-correction method using conventional radio-iodination to trace undegraded protein is useful in correcting the tissue content of trapped label for the contribution of undegraded protein.
Materials and methods

Synthesis ofthe tyramine-cellobiose adduct
Tyramine was linked to cellobiose by reductive amination with sodium cyanoborohydride (NaBH3CN) to reduce the transient Schiff base, giving a stable carbon-nitrogen bond that is not amenable to hydrolysis in cells. Cellobiose, tyramine and NaBH3CN were obtained from Sigma Chemical Co. The three reagents were solubilized at equimolar concentrations (0.12 M) in 0.2 M-sodium phosphate buffer (4.55 g of cellobiose, 1.82g of tyramine and 0.83 g of NaBH3CN in 100ml at pH 7.5). Tracer [14Cltyramine (lOO,Ci) was added to facilitate later quantification and identification of products. The mixture was allowed to react for 6 days at room temperature. It was then adjusted to pH5.5 with HCl and applied to a column (2cmx 20cm) containing a strongly acidic cation-exchange resin (Bio-Rad AG-50W; H+ form). The column was eluted with water (300-400ml) and then with 0.5 M-NH3. The material eluting with NH3, which contained the adduct and unchanged tyramine, was freeze-dried. The adduct and free tyramine were resolved by silicic acid chromatography on a 2 cm x 25 cm column eluted with butanol/acetic acid/water (7:1:2, by vol.). Tyramine preceded the product from the column, being eluted at about 50ml. The major product was eluted over the next 70ml. It was analysed by t.l.c. on silica gel, with butanol/acetic acid/water (7:1:2, by vol.) as the developing solvent. The major product stained for both carbohydrate (Partridge, 1948) and amine (Greig & Leaback, 1960) moieties. This product partially overlapped a by-product also containing both carbohydrate and amine moieties that was eluted beginning at about 90ml. The region containing the major product, but excluding the more retained by-product, was pooled and freeze-dried. Further purification was achieved by gel filtration on Sephadex G-10, which removed a lower-molecularweight component. The final product displayed one predominant band on t.l.c. with a small contaminant of slightly slower migration.
To quantify the purity of the product, the two components were resolved by paper chromatography using the developing system described above and extracted from the paper. The u.v. spectra of these components were indistinguishable from each other and from that of free tyramine. Measurement of absorbance at its maximum (279nm) disclosed 83% major component and 17% minor component, assuming equal absorption coefficients. The impurity is thought, on the basis of its staining behaviour with carbohydrate-specific and aminespecific reagents, to be the product of reaction of two molecules of cellobiose with one of tyramine. The amine group of tyramine in such a complex would not be available for further reaction. In some studies the product was prepared free of the minor component by preparative t.l.c. in the system outlined above and used in labelling studies. Alternatively, the product from silicic acid chromatography was purified to yield a single component by column chromatography on silica gel, being eluted with chloroform/methanol/water/conc. NH3 (sp.gr. 0.88) (64:31:2:3, by vol.). The behaviour of the fully purified preparation and the less pure preparation were indistinguishable. The 83%-pure preparation was stored at -6°C and used for most of the studies described here.
Radioiodination of the tyramine-cellobiose adduct and attachment to protein
The tyramine-cellobiose adduct was radioiodinated before its activation and binding to protein. lodination was performed with carrier-free radioiodide and 1,3,4,6-tetrachloro-3a,6a-diphenylglycouril, a water-insoluble oxidizing agent (lodogen; Pierce Chemical Co.) (Fraker & Speck, 1978 For all proteins except LD lipoprotein, the activated ligand was added to an appropriate amount of protein, which was at a concentration of 2-lOmg/ml in 0.1 M-sodium phosphate buffer, pH7.0-7.5. In these cases, about 0.8mol of ligand was added per mol of protein in order to obtain a product with no significant population of molecules carrying more than one ligand. Reaction was allowed to proceed for at least 1 h, at which time binding was nearly maximal. In the case of LD lipoprotein, 1,mol of ligand was allowed to react per 100mg of LD-lipoprotein protein. The reaction was carried out for 20-30min at pH 9.0-9.5. In all cases the labelled protein was made to 0.1 M with respect to NH4HCO3 and either dialysed against 0.1 M-NH4HCO3 or applied to appropriate gel-filtration columns and eluted with 0.1 M-NH4HCO3. (Columns were chosen to just exclude the protein.) At least for LD lipoprotein this exposure to NH4HCO3 was important in removing a reversibly bound fraction of the TC label. Exhaustive dialysis was then carried out against 0.154M-NaCl buffered with 0.02 M-sodium phosphate, pH 7.4, and containing 0.1% EDTA. The efficiency of ligand binding to protein was generally more than 70%. This was determined in terms of the amount of radioiodine bound to protein, corrected for that fraction of radioactivity present as unbound radioiodide. The extent of derivatization was always less than one TC residue per protein molecule, or, in the case of LD lipoprotein, less than one residue per 1OOkDa of LD lipoprotein. Specific radioactivities at the time of use of the preparations were generally 200-500c.p.m./ ng of protein.
All final preparations of labelled proteins except LD lipoprotein contained less than 1% of radioactive iodine soluble in 10% (w/v) trichloroacetic acid. LD lipoprotein contained less than 2%, but less than 5% of label was soluble in 50% (w/v) tetramethylurea, a reagent that delipidates and specifically precipitates the apo B component of LD lipoprotein (Kane, 1973) .
Labelling of non-lipoprotein proteins with the TC ligand was straightforward, and no important problems were encountered. Lipoproteins, however, were somewhat more difficult to handle. In previous studies it was found Preliminary evidence indicated that the TC ligand binds to lysine residues. This was studied by using rabbit albumin labelled with the TC ligand. The derivatized protein was exhaustively hydrolysed with Pronase before separation of the glycopeptides by gel filtration and then by affinity chromatography on a gel containing boronic acid residues, which bind vicinal hydroxy groups (Affi-Gel 601; Bio-Rad). Examination of this product by t.l.c. and amino acid analysis indicated that lysine residues were the predominant sites of attachments.
Direct radioiodination ofproteins
Conventionally radioiodinated proteins were prepared by using carrier-free radioiodide and lodogen as oxidizing agent, generally as outlined above for labelling the TC adduct. In some cases proteins were both directly iodinated and also labelled by attachment of the TC ligand. In these cases direct iodination was carried out first to avoid labelling the tyramine moiety with both iodine isotopes. About 5 mg of protein was allowed to react with Na'311 or Na'25I (usually [1] [2] [3] 
Protein preparations
Human LD lipoprotein, (d 1.02-1.06) was isolated by sequential ultracentrifugation, NaBr being used to adjust solution density (Havel et al., 1955) . Rat apo Al was prepared from high-density lipoprotein (d 1.12-1.21) as reported in detail elsewhere (Glass et al., 1983) . Fetuin and transferrin were purchased from Sigma Chemical Co. and desialylated by using neuraminidase immobilized on agarose beads as previously described (Attie et al., 1980) .
Experiments in vivo
Indwelling catheters were placed in the external jugular veins of experimental rats and rabbits under general anaesthesia the day before beginning experimental protocols. Catheters were used for injection of labelled proteins and for withdrawal of blood samples to determine plasma decay kinetics. The kinetics were determined in terms of trichloroacetic acid-precipitable label present in plasma during the time course. At termination of the experiments, animals were killed and tissues taken for radioassay as described previously (Pittman et al., 1982a,b) . In most experiments tissue pieces were placed directly into tubes for radioassay. Samples of about 1 g were used, compressed in the bottoms of the tubes. Where indicated in the Results section, radioiodine was measured in tissue homogenates, generally 1:5 (w/v) in water. Protein-bound radioiodine in these homogenates was determined after precipitation with 10% trichloroacetic acid.
To prevent re-utilization of radioiodide in those rabbits in which conventionally labelled or doubly labelled LD lipoprotein was studied, they were injected with 3 mg of NaI just before injection of the labelled protein.
In all cases when determining both 125I and "'I, appropriate window settings of the y-scintillation counter and correction factors were used to separate decay spectra of the two isotopes.
Plasma decay data were analysed as previously described (Carew & Beltz, 1982) . All curves were adequately fitted, with computer aid, to bi-exponential functions. Fractional catabolic rates were determined as described by Matthews (1957) .
Experiments with cultured cells Studies of LD lipoprotein catabolism in cultured human fibroblasts were carried out as previously described (Pittman et al., 1979a; Stein et al., 1976) . Cells were incubated in lipoprotein-deficient serum for 24 h before addition of labelled lipoprotein. Degradation of both conventionally iodinated proteins and those labelled with the TC ligand was calculated as the sum of total cell-associated radioactivity after trypsin treatment of the cells plus that appearing in the medium as radioiodide soluble in 10% trichloroacetic acid.
Results
There are two important criteria in justifying the use of an intracellularly trapped protein label: the presence of the ligand must not alter the recognition or handling of the protein by biological systems; once incorporated into cells, the labelled degradation products must be adequately trapped. Both of these criteria have been examined with the tyramine-cellobiose label in vitro and in vivo.
As Fig. 1 (Goldstein & Brown, 1977) . Radioactivity in catabolic products from 1311-LD lipoprotein was found predominantly in the medium (94%) (Fig. 1 a) . Label from ['25I-TCI-LD lipoprotein remained predominantly in the cells, with only 6% escaping to the medium as trichloroacetic acid-soluble products (Fig. lb) . Total uptakes of [125I-TCI-LD lipoprotein and '311-LD lipoprotein were the same (Fig. 1c) . In five experiments in which tetramethylurea-soluble label was less than 5% of total label (see the Materials and methods section), apparent leakage from fibroblasts of 1251-labelled catabolic products soluble in 10% trichloroacetic acid was 5.0+2.0% of total [125I-TCI-LD-lipoprotein uptake during a 24 h period in which cells were exposed to 5-50,ug of LD lipoprotein protein per ml (note that all errors in the present paper are expressed as S.D.). The 1251 in the cells was generally more than 60% soluble in trichloroacetic acid.
In the experiment shown in Fig. 2 Derivatization of proteins with the TC ligand also did not detectably alter their plasma decay in vivo. As shown in Fig. 3 , human LD lipoprotein derivatized with 1251-TC exhibited plasma decay kinetics similar to those of 131I-LD lipoprotein in rabbits (Fig. 3a) . Similarly, the decay of '25I-TC-labelled rat apo Al in rats was indistinguishable from that of 13II-apo Al (Fig. 3b) . Finally, 25 I-TC-labelled rabbit albumin decayed in rabbits like albumin directly iodinated with 1311 (Fig. 3c) . Experiments in vivo also disclosed an acceptable rate of leakage from tissues. Asialofetuin, a protein targeted for rapid uptake by liver (Ashwell & Morell, 1974) liver, where a small decrease in label content was matched by a rise in label in gut contents. Thus there was an acceptably low leakage rate, and again no evidence of label redistribution. The adequacy of trapping of the *I-TC was also studied by using asialotransferrin, a protein targeted for uptake by both liver parenchymal cells and cells of bone marrow (Regoeczi et al., 1980) . Transferrin was desialylated as described in the Materials and methods section, labelled with the '251-TC ligand, and intravenously injected into four rabbits. After 3 h, the plasma was nearly cleared of 1251 (less than 10% of that injected remaining). At that time, tissues from two rabbits were examined for 1251 content; the label was found predominantly in liver (50% of recovered 1251) and in bone marrow [27%, assuming that 3.5% of body mass represents bone marrow (Wintrobe, 1967) ]. The other two animals were killed 24 h after injection; 40% of recovered 1251 was still in the liver and 31% in bone marrow. The 10% decrease in label in liver between 3 and 24 h was accounted for in gut contents and faeces. The contents of other tissues were not significantly different at 3 and 24h. Although urinary excretion was not directly measured in these animals, it can be concluded that here again there was an acceptably low rate of leakage (assuming label in gut contents and faeces is attributable to initial uptake by liver) and no evidence for redistribution of label to other tissues.
An internal correction method for trapped undegraded TC-labelledprotein
In the studies described below, tissues were assayed at times after injection that were long compared with the plasma residence of the proteins, in all cases (except the early asialotransferrin time point) at least four times the half-time for plasma clearance. Assuming a model for catabolism of plasma proteins described by Matthews (1957) , well over 90% of the protein had been catabolized in these cases and little label remairped on intact protein. However, this would not be true of less rapidly catabolized proteins studied at short times after injection, relative to their plasma clearance rates. In those cases the presence in tissues of label on intact protein in trapped plasma and the intravascular spaces may make an important contribution to total radioactivity that is not in proportion to degradation. Unfortunately, no simple, generally applicable method for physically separating degradation products from intact protein has been found. With both the [14C]sucrose and the *I-TC intracellularly trapped labels, much of the labelled degradation products accumulating in tissues remain attached to short peptides that are in part precipitated by trichloroacetic acid and other common protein precipitants (Pittman et al., 1979b (Pittman et al., , 1982b .
We have sought to obviate this problem by using an internal-correction method to correct for label on undegraded protein. Direct iodination of tyrosine moieties was used to trace the intact protein. This approach requires that label from conventionally iodinated protein represent predominantly undegraded protein, and that label in catabolic products of conventionally iodinated protein residual in tissues be small compared with the amount of label from TC-labelled protein trapped in those tissues as catabolic products. This in turn requires that radioiodinated products from catabolism of directly iodinated protein be rapidly cleared from the tissues. These conditions are approximately met at fairly long times after injection of directly radioiodinated proteins, that is, at times long compared with the time required for processing through cells and long compared with the turnover of the body radioiodide pool (Berman, 1972; Matthews, 1957) . For example, 24h after injection of conventionally iodinated LD lipoprotein in pigs, only a small fraction of the injected dose remains in tissues, mainly as undegraded protein (Sniderman et al., 1975; Calvert etal., 1975) .
The principle of this internal-correction approach is illustrated by preliminary experiments in vitro exemplified in Fig. 4 . A rabbit was injected with LD lipoprotein labelled both with the 1251I-TC ligand and by direct iodination with 1311. It was killed 24 h later, and an homogenate prepared from the liver. This was subjected to gel filtration on 8% agarose. Of the Vol. 212 total 125I recovered, 89% was retained beyond the void volume as degradation products. In contrast, 1311 was found predominantly in the exclusion volume; 1311, therefore, traced mainly intact or nearly intact protein. When 1311 in the exclusion volume was multiplied by the 1251I/13I ratio of the original doubly labelled LD lipoprotein preparation and subtracted from-the total 1251 recovered from the column, it was calculated that only 9% of the 1251 was accounted for in intact or nearly intact LD lipoprotein. Therefore 91% of the 1251 was calculated by this method to be in degradation products, in good agreement with the 89% directly determined by retention of 1251 on gel filtration. It is noteworthy that much of the 1251 retained on 8% agarose was of molecular weight well over 1000, apparently representing the TC ligand still attached to short peptides. Only 66% of these catabolic products retained by the gbel column were soluble in 10% trichloroacetic acid.
To test the internal-correction approach in vivo, human LD by only 5% compared with method 2, and underestimation was apparent only in tissues of low catabolic activity. Where careful evaluation of the least-active tissues is needed, the more cumbersome, but precise, method 2 can be used.
Discussion
The intention of the present work was to devise a methodology, based on the principles previously developed for the sucrose trapped label, that would utilize a higher-specific-radioactivity y-radiationemitting ligand. This eliminates the laborious and imprecise procedures for determining low levels of weak fl-radiation emitters, 14C or 3H, in tissues where limited quantities of sample must be either dissolved in organic solvents for radioassay or oxidized for collection of 14CO2 or 3H20. Most importantly, the high specific radioactivity allows study of low-activity tissues, and study of slowly catabolized proteins, or proteins at low concentration in plasma where injection of a large mass of protein is not appropriate.
We have shown in the present study that the radioiodinated TC label does meet the critical requirements for an intracellularly trapped label:
Vol. 212 recognition by cells is not altered, and the label from degraded protein is effectively trapped in cells. A caveat to the latter conclusion is that leakage of label from liver after uptake of some labelled proteins, e.g. asialofetuin, is high, but this leaked label can be accounted for in faeces and gut contents. Apparently re-uptake of this material by the gut is minimal.
The TC ligand is labelled to high specific radioactivity by using carrier-free radioiodide. Specific radioactivities at least 100 times those obtained with the [14C]sucrose label are readily achieved. We have not tried to maximize specific radioactivity, but have on occasion used TC ligand labelled to the extent of almost 100mCi of 1251-pumol. At this level, efficiency of utilization of the radioiodide was more than 80% overall. If a protein of mol.wt. 50000 were to be labelled with this preparation.to the extent of one TC ligand/protein molecule, it would represent a specific radioactivity of about 4000d.p.m./ng of protein. The limitations in labelling small amounts of material to high specific radioactivity appear to lie in the chemical manipulation of small amounts of TC ligand and reagents, and in the possibility of radiation damage to the proteins.
We have used cyanuric chloride to link the TC ligand to protein. This compound contains three displaceable chlorine atoms; displacement of one de-activates the others; displacement of another further de-activates the last (Smolin & Rapaport, 1959; Chandhari & Bishop, 1972) . We have previously used the same reagent to attach ["4C]- sucrose to protein. In that case, hydroxy groups of sucrose were the attacking nucleophile; in the present case we believe that the secondary amine of the TC ligand is the attacking agent. We were concerned that the reagent might cause protein cross-linking by virtue of the third displaceable chlorine atom, although direct attempts to demonstrate such activity of the third chlorine atom have been negative (Pittman et al., 1979a) . We found evidence of extensive cross-linking only when using ['4C]sucrose to label apo Al, a protein which self-associates strongly and may hold reacting moieties in configurations particularly favourable for the cross-linking reaction. We found moderate amounts of dimerization of apo Al when using the TC ligand, and these had to be removed before study of the [251I-TCI-apo Al (Glass et al., 1983) . The lesser extent of cross-linking in the latter case may be explained by the greater de-activating effect of nitrogen compared with oxygen attached to the triazine ring of cyanuric chloride (Smolin & Rapaport, 1959; Chandhari & Bishop, 1972) , or by the use of equimolar amounts of TC ligand and cyanuric chloride in the present case so that the chance of attaching two cyanuric chloride moieties to one TC ligand was small.
An attractive feature of the methodology reported here is the double-label approach used to correct the tissues' total content of TC label for that still on intact protein. It was found that direct radioassay of pieces of tissue was adequate for determining the activities of all tissues except those least active in a protein's catabolism. This does not mean that high absolute activity of a tissue is required to obtain satisfactory results by this simple method, but only that tissues of lowest specific activity in catabolism of any given protein will be underestimated because of residual radioactive iodide or iodotyrosine. If a protein is slowly catabolized overall, the body pool of radioiodide will be proportionately low. The low-activity tissues can be accurately corrected for their content of undegraded ['25I-TCI,1311-labelled protein by homogenization and determination of protein-bound 131I, as in method 2 of Table 1 .
It has been recognized that the trapped-label methodology has applications in vitro as well as in vivo. Since the catabolic products cannot cross membranes, they are trapped in the subcellular compartment in which they are produced. Thus the trapped label allows identification of the intracellular sites of degradation of proteins and the fates of the resulting labelled products. The [I4C]sucrose label has been used for such a purpose (Attie et al., 1980; Tolleshaug & Berg, 1981) .
There may also be clinical application of the trapped-label methodology. The radioiodinated TC ligand can be used with any targeted protein to deliver radioiodine to target cells and trap it there for therapeutic purposes or for radiological imaging. Several isotopes of iodine are available with various half-lives and decay modes to suit various purposes. As a therapeutic agent, trapping would allow concentration of large amounts of isotope in target cells and increase the exposure of those cells compared with other cells. As a radiological imaging agent the trapped label would intensify the image of target cells. The double-label approach might even be used to instrumentally subtract out the contribution of undegraded protein not yet incorporated into cells, and so further enhance the sensitivity of the imaging. It also is evident that moieties other than tyramine can be attached to cellobiose for trapping so that other radionuclides or therapeutic agents may be targeted to specific tissues and cell types based on their receptor systems or other cell-surface properties.
